Related Experiment Video

Updated: May 13, 2025

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
07:03

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Published on: July 19, 2024

683

[Molecular mechanisms of hepatocarcinogenesis in MASLD]

Hayato Nakagawa1

  • 1Department of Gastroenterology and Hepatology, Mie University Graduate School of Medicine.

Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology
|May 11, 2025
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
28:15

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer

Published on: July 28, 2010

12.3K
Generation of Subcutaneous and Intrahepatic Human Hepatocellular Carcinoma Xenografts in Immunodeficient Mice
10:35

Generation of Subcutaneous and Intrahepatic Human Hepatocellular Carcinoma Xenografts in Immunodeficient Mice

Published on: September 25, 2013

35.9K

Related Experiment Videos

Last Updated: May 13, 2025

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
07:03

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Published on: July 19, 2024

683
Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
28:15

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer

Published on: July 28, 2010

12.3K
Generation of Subcutaneous and Intrahepatic Human Hepatocellular Carcinoma Xenografts in Immunodeficient Mice
10:35

Generation of Subcutaneous and Intrahepatic Human Hepatocellular Carcinoma Xenografts in Immunodeficient Mice

Published on: September 25, 2013

35.9K

Related Concept Videos

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

1.1K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.1K
Abnormal Proliferation02:23

Abnormal Proliferation

4.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.3K

Articles linked to this work by shared authors, journal, and citation graph.

SREBP-driven lipogenesis coupled with ferroptosis resistance as a therapeutic target in PTEN-loss extrahepatic cholangiocarcinoma.

JHEP reports : innovation in hepatology·2026

Systemic therapy sequence and outcomes in unresectable hepatocellular carcinoma: results from the multicenter Tokai Post ICI Sequential Therapy Registry cohort.

European journal of gastroenterology & hepatology·2026

Clinical characteristics of synchronous and metachronous superficial esophageal squamous cell carcinoma during surveillance after endoscopic submucosal dissection.

Surgical endoscopy·2026

Improved hypopharyngeal visibility and early cancer detection using the modified Killian method during esophagogastroduodenoscopy in patients at high risk of head and neck cancer.

Esophagus : official journal of the Japan Esophageal Society·2026

Safety of Argon Plasma Coagulation for Minute Synchronous Neoplasms Detected under General Anesthesia during Endoscopic Laryngopharyngeal Surgery: A Case Series.

Case reports in gastroenterology·2026

Treatment outcomes of low-radial-force self-expandable metal stent placement and palliative radiotherapy for unresectable advanced esophageal squamous cell carcinoma with dysphagia.

Esophagus : official journal of the Japan Esophageal Society·2026

[Invasive carcinoma derived from a branch-duct intraductal papillary mucinous neoplasm without mural nodules that developed after a long-term follow-up: a case report and review of literature].

Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology·2026

[A case of eosinophilic granulomatosis with polyangiitis presenting with characteristic endoscopic findings in the esophagus and stomach].

Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology·2026

[A case of primary biliary cholangitis whose pathology changed during autoimmune hepatitis].

Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology·2026

[Complete response to durvalumab+tremelimumab as second-line therapy after atezolizumab+bevacizumab in peritoneal recurrence after liver resection: a case report].

Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology·2026

[A case of ulcerative colitis with recurrence and new-onset extraintestinal manifestations during treatment for refractory proctitis and pouchitis after ileal pouch-anal anastomosis].

Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology·2026

[Aortoesophageal fistula 19 years post-chemoradiotherapy for advanced esophageal cancer:a case report].

Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology·2026

The mechanism of malignant progression in extramammary Paget's disease (EMPD): hallmarks of EMPD.

Medical molecular morphology·2026

Late Endocrine and Organ Toxicities After Treosulfan-Based Conditioning in Pediatric Hematopoietic Cell Transplantation: A Systematic Review.

Pediatric blood & cancer·2026

ENCERT: A Multisite Phase 1 Trial Using Everolimus in Combination With Nelarabine, Cyclophosphamide, and Etoposide in Relapsed T-Cell Lymphoblastic Leukemia/Lymphoma.

Pediatric blood & cancer·2026

Cathepsin D as a central regulator of extracellular matrix remodeling in wound healing and chronic tissue pathologies.

Tissue barriers·2026

Outcomes of CHOP versus CHOEP/EPOCH in aggressive adult T-cell leukemia/lymphoma: an international cohort analysis.

Haematologica·2026

"Bendamustine monotherapy induces high response rates and STAT3 inhibition in high burden T-cell large granular lymphocytic leukemia".

Haematologica·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us